A phase II, randomized, open label trial of preoperative letrozole versus letrozole (LET) in combination with bevacizumab (BEV) in post-menopausal women with newly diagnosed stage II/III breast cancer

Academic Article


Published In

Author List

  • Forero-Torres A; Rugo HS; Vaklavas C; Lin NU; Carey LA; Liu MC; Nanda R; Puhalla S; Storniolo AM; Krontiras H
  • Start Page

  • 527
  • End Page

  • 527
  • Volume

  • 31
  • Issue

  • 15